With reference to the captioned subject, this is to inform you that Board Meeting held on September 21, 2026, have inter alia consider and approved the unaudited Standalone & Consolidated Financial Results for the quarter ended June 30, 2026.
Dear Sir / Madam, With reference to the captioned subject, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., Monday, September 21, 2026, have inter alia considered and approved the Unaudited Standalone & Consolidated Financial Results for the quarter ended June 30, 2026 ('unaudited Financial Results'). Enclosed are the Unaudited Financial Results along with Limited Review Reports for your records. (Pursuant to Regulation 47 of the SEBI Listing Regulations, extract of these results will be published in newspapers). The meeting commenced at 03:30 p.m. and concluded at 04:45 p.m. The Trading Window for dealing in Company's securities shall remain closed until 48 hours from this announcement. The above information is being made available on website of the Company i.e. https://investor.symbiotec.com/performance?tab=quarterly
Pursuant to Regulation 30 and 33 of SEBI[LODR] Regulations, 2015, the Board considered and approved the Financial Results for the Financial Year ended March 31, 2026.
Please find enclosed herewith resubmission of financial results for the financial year ended 31.03.2025, as the same was submitted in XBRL Version and as a part of outcome of the Board meeting dated 11.07.2025 and in response to BSE Communication dated 18.09.2026 and earlier communication dated 15.07.2025
Submission of revised unaudited Standalone financial results of the company for quarter ended 30th June 2026, along with limited review report issued by Statutory Auditor of the Company
This is to inform that the Board of Directors, at its meeting held today i.e. Thursday, May 28, 2026 inter-alia have considered and approved the following: Audited Financial Results of the Company for the quarter and year ended March 31, 2026, To note the Resignation of M/s Laddha & Laddha as lnternal Auditors of the Company w.e.f. 31st May, 2026. 3. Appointment of M/s ARK Jain & Associates (FRN-021769C) as the lnternal Auditors of the Company for Financial Y ear 2026-27
1. Unaudited standalone Financial Results Along with Limited Review Report for the Quater ended on June 30, 2026; Accordingly, in terms of Regulation 33 of the SEBI (LODR) Regulation ,2015, we enclose herewith: 2. Unaudited standalone Financial Results along with Limited Review Report i.e. LRR for the Quater ended on June 30, 2026; and
